University of Leicester
Browse
16969995.pdf (1.21 MB)

Application of two novel electrical restitution based ECG markers of ventricular arrhythmia to patients with non-ischemic cardiomyopathy.

Download (1.21 MB)
journal contribution
posted on 2021-01-15, 10:10 authored by William B Nicolson, Matthew I Smith, Zakariyya Vali, Nilesh J Samani, G André Ng

Introduction

Sudden Cardiac Death (SCD) risk assessment is limited, particularly in patients with non-ischemic cardiomyopathies. This is the first application, in patients with cardiomyopathies, of two novel risk markers, Regional Restitution Instability Index (R2I2) and Peak Electrocardiogram Restitution Slope (PERS), which have been shown to be predictive of ventricular arrhythmias (VA) or death in ischemic heart disease patients.

Methods

Blinded retrospective study of 50 patients: 33 dilated cardiomyopathy and 17 other; undergoing electrophysiological study (EPS) for SCD risk stratification, and 29 controls with structurally normal hearts undergoing EPS. R2I2 was calculated from an EPS using ECG surrogates for action potential duration and diastolic interval. Cut-offs for high and low R2I2/PERS were predefined.

Results

R2I2 was significantly higher in study than control patients (0.99±0.05 vs. 0.63±0.04, <0.001). PERS showed a trend to higher values in the study group (1.18[0.63] vs. 1.09[0.54], p=0.07). During median follow up of 5.6 years [IQR 1.9 years] 9 study patients reached the endpoint of ventricular arrhythmia(VA)/death. Patients who experienced VA/death showed trends to higher mean R2I2 (1.14±0.07vs.0.95±0.05, p=0.12) and PERS (1.46[0.49] vs. 1.13[0.62], p=0.22). A Cox proportional hazards model using grouped markers: R2I2<1.03+PERS<1.21 / either R2I2≥1.03 or PERS≥1.21 / R2I2≥1.03+PERS≥1.21; significantly predicted VA/death (p=0.02) with a hazard ratio per positive component of 3.2 (95% confidence interval 1.2 to 8.8).

Conclusion

R2I2≥1.03+PERS≥1.21 may predict VA/death in patients with cardiomyopathies. R2I2≥1.03+PERS≥1.21 have the potential to play an important role in SCD risk stratification in cardiomyopathies but their validity should be confirmed in a larger study. This article is protected by copyright. All rights reserved.

Funding

Da Vinci Clinical Impact award

NIHR Leicester Cardiovascular Biomedical Research Unit fellowship and by a Sorin PLC grant‐in‐aid to WBN

History

Author affiliation

Department of Cardiovascular Sciences

Version

  • AM (Accepted Manuscript)

Published in

Pacing and clinical electrophysiology : PACE

Publisher

Wiley

issn

0147-8389

eissn

1540-8159

Acceptance date

2020-12-06

Copyright date

2020

Available date

2021-12-18

Spatial coverage

United States

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC